MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0176863
Market Cap
₹10.77 Cr
EMMESSA · BSE
Share Price
₹21.53
0.00% today
Revenue
₹0.37 Cr
FY 2025-26 · -39.3% YoY
EBITDA
−₹1.35 Cr
Margin -364.9%
Net Profit
₹0.45 Cr
FY 2025-26 · +50.0% YoY
P/E (TTM)
29.8x
P/B 1.5x
ROE
5.6%
ROCE 6.7%
Authorised capital
₹5.4 Cr
Registered with MCA
About Emmessar Biotech and Nutrition Ltd
Data last updated:
Emmessar Biotech and Nutrition Ltd is a public limited company based in Raigad, Maharashtra, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 17 March 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24110MH1992PLC065942. Its GSTIN is 27AAACE1152E1Z7 (Maharashtra). It is a listed company as per MCA records. Its shares are listed on BSE: 524768.
The company has an authorised share capital of ₹5.4 Cr and a paid-up capital of ₹5 Cr. It was formerly known as Emmessar Chmical Industries Ltd. It is led by directors including Srinivasa Raghavan Mathurakavi Ayyangar (Managing Director) and Jeyavel Balaiah Nadar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No T/3/2 MIDC Area P Obox 39 Taloja, Raigad, Maharashtra, India – 410208.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹37 Lakh, a decline of 39.3% compared to the previous year. For the same year it recorded a net profit of ₹45 Lakh (net margin 121.6%) and EBITDA of -₹1.35 Cr (EBITDA margin -364.9%). The net worth stands at ₹8.12 Cr (up 5.3% YoY). Total assets are valued at ₹8.87 Cr (up 5.2% YoY).
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Emmessar Biotech & Nutrition. As per MCA filings, the company has satisfied charges of ₹1.1 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 15 deals on record (15 market trades); the latest was in March 2026. Its 4 peer companies in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Maxener Wellness Limited with revenue of ₹2.64 Cr.
Emmessar Biotech and Nutrition Ltd is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0176863). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ebnl.org.
Company details
CIN L24110MH1992PLC065942
Registration Number 065942
Incorporation Date 17 March 1992
ROC Mumbai
Listing Status Listed - Listed on BSE (524768)
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0176863
CIN history
Emmessar Biotech and Nutrition has one previous CIN (Corporate Identification Number): U24110MH1992PLC065942. The current CIN is L24110MH1992PLC065942, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24110MH1992PLC065942 | Current |
| U24110MH1992PLC065942 | Previous |
Key People
Srinivasa Raghavan Mathurakavi Ayyangar Managing Director Jeyavel Balaiah Nadar Whole-Time Director Anuradha Srinivasa Raghavan Director Recognitions & Rankings of Emmessar Biotech and Nutrition
Contact details
Emmessar Biotech and Nutrition Ltd's registered office is in Raigad, Maharashtra. Its website is ebnl.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No T/3/2 MIDC Area P Obox 39 Taloja, Raigad, Maharashtra, India – 410208
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Emmessar Biotech and Nutrition Ltd, buy the company report.
Comprehensive company report
Emmessar Biotech and Nutrition Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Emmessar Biotech and Nutrition operates one associated brand: Emmessar Biotech & Nutrition. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Herbal healthcare and nutritional products are manufactured. | ebnl.org |
Business activity
The main business activities of Emmessar Biotech and Nutrition are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Emmessar Biotech and Nutrition Ltd, buy the company report.
Financials of Emmessar Biotech and Nutrition Ltd
FY 2025-26 filings availableEmmessar Biotech and Nutrition Ltd reported revenue of ₹37 Lakh (down 39.3% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹0.37 Cr
-39.3% YoY
EBITDA
−₹1.35 Cr
-39.2% YoY
Profit After Tax
₹0.45 Cr
+50.0% YoY
Net Worth
₹8.12 Cr
+5.3% YoY
Total Assets
₹8.87 Cr
+5.2% YoY
Total Debt
Nil
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 0.37 | 0.61 | 0.56 | 1.02 | 0.36 | 6.99 | 3.40 |
| Revenue growth | -39.3% | +8.9% | -45.1% | +183.3% | -94.9% | +105.6% | - |
| EBITDA | (1.35) | (0.97) | (1.08) | (0.70) | (0.91) | 0.86 | (0.67) |
| EBITDA margin | -364.9% | -159.0% | -192.9% | -68.6% | -252.8% | +12.3% | -19.7% |
| Profit before tax | 0.59 | 0.94 | 0.81 | 0.96 | 0.92 | 2.27 | 0.74 |
| Net profit | 0.45 | 0.30 | 0.75 | 0.50 | 0.47 | 1.46 | 0.97 |
| Net profit margin | +121.6% | +49.2% | +133.9% | +49.0% | +130.6% | +20.9% | +28.5% |
| EPS (₹) | 0.81 | 0.63 | 1.50 | 1.01 | 0.95 | 2.90 | 1.51 |
| Balance sheet | |||||||
| Total assets | 8.87 | 8.43 | 8.24 | 7.47 | 6.88 | 6.40 | 5.03 |
| Net worth | 8.12 | 7.71 | 7.41 | 6.67 | 6.17 | 5.70 | 4.27 |
| Total debt | 0.00 | 0.00 | 0.11 | 0.08 | 0.00 | 0.00 | 0.00 |
| Cash & bank | 7.32 | 6.87 | 6.18 | 5.19 | 4.58 | 2.47 | 1.88 |
| Net working capital | 7.43 | 6.91 | 6.42 | 5.59 | 4.51 | 3.99 | 2.16 |
| Cash flow | |||||||
| Cash from operations | 0.27 | 0.22 | 0.64 | 0.38 | 2.27 | 0.47 | 1.03 |
| Cash from investing | (0.26) | (0.23) | (0.64) | (0.55) | (2.61) | 0.01 | (1.06) |
| Cash from financing | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.11 | 0.06 | 0.09 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 |
| Revenue growth (YoY) | +22.2% | -33.3% | -10.0% | -10.0% | -73.5% | +12.5% | - | - |
| Other income | 0.52 | 0.54 | 0.47 | 0.49 | 0.54 | 0.53 | 0.61 | 0.43 |
| Total expenses | 0.43 | 0.41 | 0.46 | 0.43 | 0.46 | 0.37 | 0.42 | 0.38 |
| EBITDA | (0.32) | (0.35) | (0.37) | (0.34) | (0.37) | (0.28) | (0.32) | (0.28) |
| EBITDA margin | -290.9% | -583.3% | -411.1% | -377.8% | -411.1% | -311.1% | -320.0% | -280.0% |
| Depreciation | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.18 | 0.17 | 0.07 | 0.12 | 0.14 | 0.23 | 0.27 | 0.13 |
| Tax | 0.03 | 0.03 | 0.04 | 0.01 | 0.03 | 0.06 | 0.33 | 0.11 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 03 Nov 2026
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.11 | 0.06 | 0.09 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 |
| Revenue growth (YoY) | +22.2% | -33.3% | -10.0% | -10.0% | -73.5% | +12.5% | - | - |
| Other income | 0.52 | 0.54 | 0.47 | 0.49 | 0.54 | 0.53 | 0.61 | 0.43 |
| Total expenses | 0.43 | 0.41 | 0.46 | 0.43 | 0.46 | 0.37 | 0.42 | 0.38 |
| EBITDA | (0.32) | (0.35) | (0.37) | (0.34) | (0.37) | (0.28) | (0.32) | (0.28) |
| EBITDA margin | -290.9% | -583.3% | -411.1% | -377.8% | -411.1% | -311.1% | -320.0% | -280.0% |
| Depreciation | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.18 | 0.17 | 0.07 | 0.12 | 0.14 | 0.23 | 0.27 | 0.13 |
| Tax | 0.03 | 0.03 | 0.04 | 0.01 | 0.03 | 0.06 | 0.33 | 0.11 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.37 | 0.61 | 0.56 | 1.02 | 0.36 | 6.99 | 3.40 |
| Revenue growth | -39.3% | +8.9% | -45.1% | +183.3% | -94.9% | +105.6% | - |
| Other income | 2.04 | 2.01 | 1.99 | 1.75 | 1.92 | 1.47 | 1.47 |
| Total expenses | 1.72 | 1.58 | 1.64 | 1.72 | 1.27 | 6.13 | 4.07 |
| Employee cost | 0.00 | 0.93 | 0.96 | 0.84 | 0.77 | 0.64 | 0.58 |
| EBITDA | (1.35) | (0.97) | (1.08) | (0.70) | (0.91) | 0.86 | (0.67) |
| EBITDA margin | -364.9% | -159.0% | -192.9% | -68.6% | -252.8% | +12.3% | -19.7% |
| Depreciation | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.06 | 0.06 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.59 | 0.94 | 0.81 | 0.96 | 0.92 | 2.27 | 0.74 |
| Tax | 0.14 | 0.64 | 0.06 | 0.46 | 0.45 | 0.81 | (0.02) |
| Net profit | 0.45 | 0.30 | 0.75 | 0.50 | 0.47 | 1.46 | 0.97 |
| Net profit margin | +121.6% | +49.2% | +133.9% | +49.0% | +130.6% | +20.9% | +28.5% |
| EPS (₹) | 0.81 | 0.63 | 1.50 | 1.01 | 0.95 | 2.90 | 1.51 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Reserves & surplus | 3.12 | 2.71 | 2.41 | 1.67 | 1.17 | 0.70 | (0.73) |
| Shareholders' funds (net worth) | 8.12 | 7.71 | 7.41 | 6.67 | 6.17 | 5.70 | 4.27 |
| Secured loans | 0.00 | 0.00 | 0.11 | 0.08 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.00 | 0.00 | 0.11 | 0.08 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 8.87 | 8.43 | 8.24 | 7.47 | 6.88 | 6.40 | 5.03 |
| Assets | |||||||
| Gross block | 2.94 | 2.93 | 2.93 | 2.93 | 2.91 | 2.60 | 2.60 |
| Net block | 1.72 | 1.81 | 1.90 | 2.00 | 2.08 | 1.86 | 1.92 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Inventories | 0.10 | 0.12 | 0.09 | 0.14 | 0.07 | 0.07 | 1.15 |
| Sundry debtors | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 2.71 | 0.03 |
| Cash & bank balances | 7.32 | 6.87 | 6.18 | 5.19 | 4.58 | 2.47 | 1.88 |
| Loans & advances | 0.62 | 0.58 | 0.53 | 0.59 | 0.19 | 0.14 | 0.20 |
| Total current assets | 8.06 | 7.59 | 6.82 | 5.93 | 4.85 | 5.39 | 3.26 |
| Total current liabilities | 0.63 | 0.68 | 0.40 | 0.34 | 0.34 | 1.40 | 1.10 |
| Net working capital | 7.43 | 6.91 | 6.42 | 5.59 | 4.51 | 3.99 | 2.16 |
| Total assets | 8.87 | 8.43 | 8.24 | 7.47 | 6.88 | 6.40 | 5.03 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.01 | 0.01 | 0.01 | 0.18 | 0.53 | 0.05 | 0.08 |
| Net cash from operating activities | 0.27 | 0.22 | 0.64 | 0.38 | 2.27 | 0.47 | 1.03 |
| Net cash from investing activities | (0.26) | (0.23) | (0.64) | (0.55) | (2.61) | 0.01 | (1.06) |
| Net cash from financing activities | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net change in cash | 0.02 | 0.00 | 0.00 | (0.17) | (0.34) | 0.48 | (0.03) |
| Closing cash | 7.32 | 6.87 | 6.18 | 5.19 | 4.58 | 2.47 | 1.88 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -39.3% | +8.9% | -45.1% | +183.3% | -94.9% | +105.6% | - |
| EBITDA growth | -39.2% | +10.2% | -54.3% | +23.1% | -205.8% | +228.4% | - |
| PBT growth | -39.4% | +16.1% | -15.6% | +4.4% | -59.5% | +206.8% | +164.3% |
| Net income growth | +50.0% | -60.0% | +50.0% | +6.4% | -67.8% | +50.5% | - |
| Revenue CAGR (3Y) | -28.7% | +19.2% | -56.9% | -33.1% | -17.0% | +76.6% | +9.2% |
| EBITDA CAGR (3Y) | +25.1% | +2.2% | - | +1.5% | -1.1% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +116.2% | +49.2% | +133.9% | +49.0% | +130.6% | +20.9% | +22.4% |
| Return on capital employed | +6.7% | +11.5% | +10.3% | +13.4% | +14.2% | +37.1% | +17.1% |
| Return on net worth | +5.6% | +4.2% | +10.7% | +7.8% | +8.1% | +27.2% | +19.3% |
| Debt / equity | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.13 | 0.21 | 0.19 | 0.35 | 0.13 | 2.69 | 1.30 |
| Inventory turnover | 3.36 | 5.81 | 4.87 | 9.71 | 5.14 | 11.46 | 3.62 |
| Debtors turnover | 18.50 | 30.50 | 37.33 | 102.00 | 0.26 | 5.10 | 97.14 |
| EPS (₹) | 0.87 | 0.63 | 1.50 | 1.01 | 0.95 | 2.90 | 1.51 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 16.24 | 15.43 | 14.82 | 13.34 | 12.35 | 11.41 | 8.53 |
To see the full year-wise statements and ratios of Emmessar Biotech and Nutrition Ltd, buy the company report.
Board of directors of Emmessar Biotech and Nutrition Ltd
Emmessar Biotech and Nutrition has 7 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuradha Srinivasa Raghavan Also directs: Emmessar Technologies Private Limited | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
| Sarada Srinivasa Raghavan Also directs: Emmessar Global Partners LLP, Qyuradyne Biotech Private Limited | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
| Jeyavel Balaiah Nadar Also directs: Emmessar Technologies Private Limited | Whole-Time Director | 06 Feb 2021 | 5 Years 8 Months | Current |
| Srinivasa Raghavan Mathurakavi Ayyangar Also directs: Emmessar Technologies Private Limited | Managing Director | 17 Mar 1992 | 34 Years 7 Months | Current |
| Milind Sitaram Desai Also directs: Industrial Investment Trust Limited | Director | 20 Oct 2022 | 4 Years 0 Months | Current |
| Veeraraghavan Ranganathan | Director | 27 Oct 2023 | 3 Years 0 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Emmessar Biotech and Nutrition Ltd is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxener Wellness Limited | ₹2.64 Cr (FY 2025) | -54.0% | Ahmedabad, Gujarat, India | |||
| Shahjadi Pharmaceutical Private Limited | ₹2.63 Cr (FY 2018) | 448.0% | Panchodi, Rajasthan, India | |||
| Sagius Lifesciences Limited | ₹2.62 Cr (FY 2025) | 23.0% | New Delhi, Delhi, India | |||
| Maas Herbals Private Limited | ₹2.6 Cr (FY 2016) | -26.0% | Bangalore, Karnataka, India | |||
| Emmessar Biotech and Nutrition Ltdthis company | ₹37 Lakh (FY 2026) | ₹45 Lakh | 121.6% | -39.3% | 14 | Raigad, Maharashtra, India |
To see the full peer comparison of Emmessar Biotech and Nutrition Ltd, buy the company report.
Auditor
Emmessar Biotech and Nutrition Ltd is audited by V. NAGARAJAN & CO. for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V. NAGARAJAN & CO. | FY 2025 | 004879N |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 59.50%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.20% and retail and other public shareholders hold 40.30%.
Mar 2026
QUARTER
59.50% Promoters
0.20% DII (Domestic Institutional)
40.30% Retail & Others
Promoter holding - history
Now 59.50% · Mar 2026High 59.50% · Jun 2025Low 59.50% · Jun 2025
Shareholding trend - last 6 quarters
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 59.50% | 59.50% | 59.50% | 59.50% |
| Public | 40.50% | 40.50% | 40.50% | 40.50% |
Charges & borrowings
Open charges
None
Satisfied charges
₹1.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Dec 1994 | 90150301 | Idbi Bank | ₹1.1 Cr | Satisfied |
To see the full charge records of Emmessar Biotech and Nutrition Ltd, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Emmessar Biotech and Nutrition Ltd has 15 deals on record (15 market trades); the latest was in March 2026.
Total deals
15
Market trades
15
Deals on record (5 of 15)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2026 | Market trade | ₹11.1 Lakh | Buyer: Aims Financial Ventures Seller: an individual |
| Jul 2025 | Market trade | ₹7.4 Lakh | Seller: Quantseye AI Private Limited |
| Dec 2024 | Market trade | ₹16.6 Lakh | Buyer: an individual Seller: an individual |
| Nov 2024 | Market trade | ₹13.4 Lakh | Buyer: an individual Seller: Aims Financial Ventures |
| Oct 2024 | Market trade | ₹36.4 Lakh | Buyer: Aims Financial Ventures, an individual Seller: an individual |
To see the full deal history of Emmessar Biotech and Nutrition Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Emmessar Biotech and Nutrition Ltd has 1 court case on record: 1 filed by Emmessar Biotech and Nutrition. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Writ petition | Filed by the company against The State of Maharashtra THR the Government Pleader and Ors and 7 others | Disposed |
To see the full case history of Emmessar Biotech and Nutrition Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emmessar Biotech and Nutrition Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Emmessar Biotech and Nutrition Ltd has a workforce of 14 employees on its EPFO records as of Oct 08, 2025, across 1 active EPFO establishment.
Employee count
14
Active EPFO establishments
1
Employee growth
-6.67%
GST
Emmessar Biotech and Nutrition has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACE1152E1Z7 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Emmessar Biotech and Nutrition Ltd, buy the company report.
Recent activity
Emmessar Biotech and Nutrition Ltd has 25 board changes on record since 1992: 16 appointments and 9 cessations. The latest: Anantharama Sethumani Subramanian ceased to be Director on 06 Feb 2025.
Filing
Emmessar Biotech And Nutrition Ltd has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
AGM
Emmessar Biotech And Nutrition Ltd last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Ceased
Anantharama Sethumani Subramanian ceased to be Director.
Ceased
Rajalakshmi Srinivasa Raghavan ceased to be Director.
Charges
A charge registered on 16 Dec 1994 via Charge ID 90150301 with Idbi Bank was fully satisfied on 26 Jul 2024.
Appointed
Dinesh Kumar Deora was appointed as Director.
Appointed
Veeraraghavan Ranganathan was appointed as Director.
Ceased
Ashok Manilal Kadakia ceased to be Director.
Appointed
Milind Sitaram Desai was appointed as Director.
Ceased
Vijaykumar Raghunandanprasad Agrawal ceased to be Director.
Appointed
Rajalakshmi Srinivasa Raghavan was appointed as Director.
Appointed
Jeyavel Balaiah Nadar was appointed as Whole-Time Director.
19 earlier events are in the company report.
Frequently asked questions
Emmessar Biotech and Nutrition is an active public limited company based in Raigad, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 17 March 1992 (34+ years old) and is registered under CIN L24110MH1992PLC065942. Listed on BSE: 524768.
Emmessar Biotech and Nutrition reported revenue of ₹37 Lakh for FY 2025-26 (down 39.3% YoY) based on standalone financials.
Emmessar Biotech and Nutrition has 7 current directors:
- Srinivasa Raghavan Mathurakavi Ayyangar - Managing Director
- Jeyavel Balaiah Nadar - Whole-Time Director
- Anuradha Srinivasa Raghavan - Director
- Sarada Srinivasa Raghavan - Director
- Milind Sitaram Desai - Director
- Veeraraghavan Ranganathan - Director
- Dinesh Kumar Deora - Director
The latest financial statements of Emmessar Biotech and Nutrition on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Emmessar Biotech and Nutrition is 27AAACE1152E1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Emmessar Biotech and Nutrition is L24110MH1992PLC065942. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Emmessar Biotech and Nutrition is a listed company as per MCA records. Its shares are listed on BSE (code: 524768).
Emmessar Biotech and Nutrition has 1 court case on record: 1 filed by the company.
Emmessar Biotech and Nutrition was incorporated on 17 March 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.
Emmessar Biotech and Nutrition has 15 deals on record (15 market trades); the latest was in March 2026.
The peers of Emmessar Biotech and Nutrition by revenue are Maxener Wellness Limited, Shahjadi Pharmaceutical Private Limited, Sagius Lifesciences Limited, Maas Herbals Private Limited, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages